Lead author Professor Sunil Badve, professorial fellow at The George Institute for Global Health and UNSW Sydney, said the study expanded current knowledge about the drugs in key areas, including benefits in people with chronic kidney disease (CKD), and in people with and without diabetes
October 4, 2024: Lawsuits Against Eli Lilly Escalate as Trulicity Side Effect Concerns Grow The number of lawsuits targeting GLP-1 drug manufacturers, including Eli Lilly, the maker of Trulicity, saw a 20% increase between August and September
Alongside Mounjaro, our health coaches are here to support you in building sustainable habits in nutrition , exercise , sleep , and mindset
Ransohoff RM (2018) All (animal) models (of neurodegeneration) are wrong
Choosing between Survodutide and Tirzepatide depends on various factors, including availability, individual health status, treatment goals, and physician recommendations
Curr Drug Metab 2006